All Stories

  1. Preclinical and Clinical Development of a YFV 17 D-Based Chimeric Vaccine against West Nile Virus

    Article • Viruses, December 2013, MDPI AG

    Dr Thomas P. Monath, Dr Gustavo H Dayan

  2. Safety and immunogenicity of three tetravalent dengue vaccine formulations in healthy adults in the USA

    Article • Vaccine, October 2013, Elsevier

    Dr Gustavo H Dayan

  3. Safety and Immunogenicity of a Recombinant Tetravalent Dengue Vaccine in 9–16 Year Olds

    Article • The Pediatric Infectious Disease Journal, October 2013, Wolters Kluwer Health

    Dr Gustavo H Dayan

  4. Live-attenuated Tetravalent Dengue Vaccine in Dengue-naïve Children, Adolescents, and Adults in Mexico City

    Article • The Pediatric Infectious Disease Journal, January 2011, Wolters Kluwer Health

    Dr Gustavo H Dayan

  5. Seroprevalence of Antibody to Mumps Virus in the US Population, 1999–2004

    Article • The Journal of Infectious Diseases, September 2010, Oxford University Press (OUP)

    Dr Gustavo H Dayan

  6. Guidance for Isolation Precautions for Mumps in the United States: A Review of the Scientific Basis for Policy Change

    Article • Clinical Infectious Diseases, June 2010, Oxford University Press (OUP)

    Dr Gustavo H Dayan

  7. Mumps Outbreaks in Vaccinated Populations: Are Available Mumps Vaccines Effective Enough to Prevent Outbreaks?

    Article • Clinical Infectious Diseases, December 2008, Oxford University Press (OUP)

    Dr Gustavo H Dayan

  8. Long‐Term Persistence of Mumps Antibody after Receipt of 2 Measles‐Mumps‐Rubella (MMR) Vaccinations and Antibody Response after a Third MMR Vaccination among a University Population

    Article • The Journal of Infectious Diseases, June 2008, Oxford University Press (OUP)

    Dr Gustavo H Dayan

  9. Mumps Vaccine Performance among University Students during a Mumps Outbreak

    Article • Clinical Infectious Diseases, April 2008, Oxford University Press (OUP)

    Dr Gustavo H Dayan

  10. Recent Resurgence of Mumps in the United States

    Article • New England Journal of Medicine, April 2008, New England Journal of Medicine (NEJM/MMS)

    Dr Gustavo H Dayan

  11. Seroprevalence of Measles Antibody in the US Population, 1999–2004

    Article • The Journal of Infectious Diseases, November 2007, Oxford University Press (OUP)

    Dr Gustavo H Dayan

  12. Medical practices for prevention of perinatal infections in Puerto Rico

    Article • Paediatric and Perinatal Epidemiology, November 2007, Wiley

    Dr Gustavo H Dayan

  13. Serologic Response to Inactivated Poliovirus Vaccine: A Randomized Clinical Trial Comparing 2 Vaccination Schedules in Puerto Rico

    Article • The Journal of Infectious Diseases, January 2007, Oxford University Press (OUP)

    Dr Gustavo H Dayan

  14. Implications of a 2005 Measles Outbreak in Indiana for Sustained Elimination of Measles in the United States

    Article • New England Journal of Medicine, August 2006, New England Journal of Medicine (NEJM/MMS)

    Dr Gustavo H Dayan

  15. Tracking vaccine lot lifecycles using reports to the Vaccine Adverse Event Reporting System (VAERS)

    Article • Pharmacoepidemiology and Drug Safety, January 2005, Wiley

    Dr Gustavo H Dayan

  16. Assessment of areas at increased risk for poliovirus circulation in Ecuador

    Article • Epidemiology and Infection, October 2004, Cambridge University Press

    Dr Gustavo H Dayan

  17. Impact of Haemophilus influenzae Type b Conjugate Vaccine in South Africa and Argentina

    Article • The Pediatric Infectious Disease Journal, September 2004, Wolters Kluwer Health

    Dr Gustavo H Dayan

  18. Vaccination coverage among children aged 13 to 59 months in Buenos Aires, Argentina, 2002

    Article • Revista Panamericana de Salud Pública, September 2004, FapUNIFESP (SciELO)

    Dr Gustavo H Dayan

  19. Cost-effectiveness of three different vaccination strategies against measles in Zambian children

    Article • Vaccine, January 2004, Elsevier

    Dr Gustavo H Dayan

  20. Investigation of a Rubella Outbreak in Kyrgyzstan in 2001: Implications for an Integrated Approach to Measles Elimination and Prevention of Congenital Rubella Syndrome

    Article • The Journal of Infectious Diseases, May 2003, Oxford University Press (OUP)

    Dr Gustavo H Dayan

  21. Cost-effectiveness of influenza vaccination in high-risk children in Argentina

    Article • Vaccine, July 2001, Elsevier

    Dr Gustavo H Dayan